Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma

被引:60
作者
Pan, Quintin
Bao, Li Wei
Teknos, Theodoros N.
Merajver, Sofia D.
机构
[1] Univ Michigan Hlth Syst, Div Hematol & Oncol, Dept Internal Med, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Dept Otolaryngol, Ann Arbor, MI USA
[3] Univ Michigan Hlth Syst, Ctr Comprehens Canc, Ann Arbor, MI USA
关键词
D O I
10.1158/0008-5472.CAN-06-2646
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Over 70% of patients with head and neck squamous cell carcinoma (HNSCC) present with locoregionally advanced stage III and IV disease. In spite of aggressive therapy, locoregional disease recurs in 60% and metastatic disease develops in 15% to 25% of patients causing a major decline in quality and length of life. Therefore, there is a need to identify and understand genes that are responsible for inducing an aggressive HNSCC phenotype. Evidence has shown that protein kinase C (PKC) epsilon is a transforming oncogene and may play a role in HNSCC progression. In this study, we determine the downstream signaling pathway mediated by PKC epsilon to promote an aggressive HNSCC phenotype. RNA interference knockdown of PKC epsilon in UMSCC11A and UMSCC36, two highly invasive and motile HNSCC cell lines with elevated endogenous PKC epsilon levels, resulted in cells that were significantly less invasive and motile than the small interfering RNA-scrambled control transfectants; 51 +/- 5% (P < 0.006) and 49 +/- 3% (P < 0.010) inhibition in invasion and 69 +/- 1% (P < 0.0005) and 66 3% (P < 0.0001) inhibition in motility, respectively. PKCE-deficient UMSCC11A clones had reduced levels of active and serine-phosphorylated RhoA and RhoC. Moreover, constitutive active RhoA completely rescued the invasion and motifity defect, whereas constitutive active RhoC completely rescued the invasion and partially rescued the motility defect of PKC epsilon-deficient UMSCC11A clones. These results indicate that RhoA and RhoC are downstream of PKC epsilon and critical for PKC epsilon-mediated cell invasion and motility. Our study shows, for the first time, that PKCe is involved in a coordinated regulation of RhoA and RhoC activation, possibly through direct post-translational phosphorylation.
引用
收藏
页码:9379 / 9384
页数:6
相关论文
共 25 条
[1]   Motility-related proteins as markers for head and neck squamous cell cancer [J].
Abraham, MT ;
Kuriakose, MA ;
Sacks, PG ;
Yee, H ;
Chiriboga, L ;
Bearer, EL ;
Delacure, MD .
LARYNGOSCOPE, 2001, 111 (07) :1285-1289
[2]  
Brouns MR, 2000, DEVELOPMENT, V127, P4891
[3]  
CACACE AM, 1993, ONCOGENE, V8, P2095
[4]  
Carter Charleata A., 2000, Current Drug Targets, V1, P163, DOI 10.2174/1389450003349317
[5]   OVERVIEW OF COMBINED MODALITY THERAPIES FOR HEAD AND NECK-CANCER [J].
DIMERY, IW ;
HONG, WK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (02) :95-111
[6]   Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor [J].
Dong, G ;
Lee, TL ;
Yeh, NT ;
Geoghegan, J ;
Van Waes, C ;
Chen, Z .
ONCOGENE, 2004, 23 (37) :6199-6208
[7]   Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters [J].
Fritz, G ;
Brachetti, C ;
Bahlmann, F ;
Schmidt, M ;
Kaina, B .
BRITISH JOURNAL OF CANCER, 2002, 87 (06) :635-644
[8]  
Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO
[9]  
2-B
[10]   Neck disease and distant metastases [J].
Genden, EM ;
Ferlito, A ;
Bradley, PJ ;
Rinaldo, A ;
Scully, C .
ORAL ONCOLOGY, 2003, 39 (03) :207-212